Product NDC: | 64543-350 |
Proprietary Name: | Liquibid D-R |
Non Proprietary Name: | Guaifenesin and Phenylephrine |
Active Ingredient(s): | 400; 10 mg/1; mg/1 & nbsp; Guaifenesin and Phenylephrine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, MULTILAYER |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64543-350 |
Labeler Name: | Capellon Pharmaceuticals, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20080618 |
Package NDC: | 64543-350-02 |
Package Description: | 2 TABLET, MULTILAYER in 1 BLISTER PACK (64543-350-02) |
NDC Code | 64543-350-02 |
Proprietary Name | Liquibid D-R |
Package Description | 2 TABLET, MULTILAYER in 1 BLISTER PACK (64543-350-02) |
Product NDC | 64543-350 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Guaifenesin and Phenylephrine |
Dosage Form Name | TABLET, MULTILAYER |
Route Name | ORAL |
Start Marketing Date | 20080618 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Capellon Pharmaceuticals, LLC |
Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 400; 10 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |